Calcimimetics inhibit renal pathology in rodent nephronophthisis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Kidney International

• Publication date

  2011-09-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ki.2011.139PMID 21633408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells.

  2010cited by this paper
• Calcium metabolism in health and disease.

  2010cited by this paper
• Disease Stage Characterization of Hepatorenal Fibrocystic Pathology in the PCK Rat Model of ARPKD

  2010cited by this paper
• Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR).

  2010cited by this paper
• The role of the calcium-sensing receptor in the development and progression of cancer.

  2009cited by this paper
• Autosomal dominant polycystic kidney disease: the last 3 years.

  2009cited by this paper
• Calcium-sensing receptor in cancer: good cop or bad cop?

  2009cited by this paper
• Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells.

  2009cited by this paper
• Calcimimetic inhibits late-stage cyst growth in ADPKD.

  2009cited by this paper
• Impaired Wnt–β-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy

  2009cited by this paper
• The functions and roles of the extracellular Ca2+-sensing receptor along the gastrointestinal tract.

  2009cited by this paper
• Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease

  2008cited by this paper
• Inactivation of the Calcium Sensing Receptor Inhibits E-cadherin-mediated Cell-Cell Adhesion and Calcium-induced Differentiation in Human Epidermal Keratinocytes*

  2008cited by this paper
• Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat.

  2008cited by this paper
• Parathyroid-specific interaction of the calcium-sensing receptor and G alpha q.

  2008cited by this paper
• The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics.

  2007cited by this paper
• Fibrocystin/Polyductin, Found in the Same Protein Complex with Polycystin-2, Regulates Calcium Responses in Kidney Epithelia

  2007cited by this paper
• Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands.

  2005cited by this paper
• Termination of cAMP signals by Ca2+ and G(alpha)i via extracellular Ca2+ sensors: a link to intracellular Ca2+ oscillations.

  2005cited by this paper
• Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways

  2005cited by this paper
• Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.

  2005cited by this paper
• Autosomal recessive polycystic kidney disease

  2004cited by this paper
• Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype*

  2004cited by this paper
• Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach.

  2003cited by this paper
• Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis

  2003cited by this paper
• Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels.

  2003cited by this paper
• Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells

  2003cited by this paper
• Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

  2003cited by this paper
• Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells.

  2003cited by this paper
• Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease.

  2002cited by this paper
• Molecular genetics of nephronophthisis and medullary cystic kidney disease.

  2000cited by this paper
• Physiology and pathophysiology of the extracellular calcium-sensing receptor.

  1999cited by this paper
• Autosomal recessive polycystic kidney disease

  1998cited by this paper
• Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct.

  1997cited by this paper
• Localization of the extracellular Ca(2+)-sensing receptor and PTH/PTHrP receptor in rat kidney.

  1996cited by this paper
• Autosomal recessive polycystic kidney disease

  1992cited by this paper

• A miRNA-Based Approach in Autosomal Dominant Polycystic Kidney Disease: Challenges and Insights from Adult to Pediatric Evidence

  2025cites this paper
• Targeting GLP-1 Signaling Ameliorates Cystogenesis in a Zebrafish Model of Nephronophthisis

  2025cites this paper
• Genome-Based Advances in Modeling Renal Ciliopathies and Enhancing Patient Care

  2025cites this paper
• Renal ciliopathies.

  2025cites this paper
• The uremic toxin indoxyl sulfate decreases osteocyte RANKL/OPG and increases Wnt inhibitor RNA expression that is reversed by PTH

  2024cites this paper
• Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights

  2024cites this paper
• Renal ciliopathies: promising drug targets and prospects for clinical trials

  2023cites this paper
• Autosomal Dominant Polycystic Kidney Disease Therapies on the Horizon.

  2023cites this paper
• Repurposing small molecules for Nephronophthisis and related renal ciliopathies.

  2023cites this paper
• Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling

  2022cites this paper
• Therapeutic advances in ADPKD: the future awaits

  2021cites this paper
• Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease

  2021cites this paper
• Pre‐clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease

  2021cites this paper
• Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis

  2021cites this paper
• Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

  2020cites this paper
• Dietary Phosphate Restriction Attenuates Polycystic Kidney Disease in Mice.

  2019cites this paper
• Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions

  2019cites this paper
• Cilia and Polycystic Kidney Disease

  2018cites this paper
• Transcription factor HNF1β regulates expression of the calcium-sensing receptor in the thick ascending limb of the kidney.

  2018cites this paper
• Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells

  2018cites this paper
• Fundamental insights into autosomal dominant polycystic kidney disease from human-based cell models

  2018cites this paper
• Clinical and genetic characteristics of Japanese nephronophthisis patients

  2016cites this paper
• Nephronophthisis: should we target cysts or fibrosis?

  2016cites this paper
• The Role of Calcium and Cyclic AMP in PKD

  2015cites this paper
• Vasopressin and disruption of calcium signalling in polycystic kidney disease

  2015cites this paper
• Cytoskeletal changes induced by allosteric modulators of calcium-sensing receptor in esophageal epithelial cells

  2015cites this paper
• The clinicogenetic features of Japanese patients with nephronophthisis

  2015cites this paper
• Pathogenesis of arrhythmias in a model of CKD.

  2014cites this paper
• Calcium-sensing receptor activation in chronic kidney disease: effects beyond parathyroid hormone control.

  2014cites this paper
• Dichloroacetate treatment accelerates the development of pathology in rodent autosomal recessive polycystic kidney disease.

  2014cites this paper
• Experimental therapies and ongoing clinical trials to slow down progression of ADPKD.

  2013cites this paper
• Renal Cilia Structure, Function, and Physiology

  2013cites this paper
• Chapter 80 – Autosomal Dominant Polycystic Kidney Disease

  2013cites this paper
• Preclinical and clinical trials for identifying treatments for polycystic kidney disease

  2013cites this paper
• Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease

  2012cites this paper
• Loss of GM 3 synthase gene , but not sphingosine kinase 1 , is protective against murine nephronophthisis-related polycystic kidney disease

  2012cites this paper